Fozivudine tidoxil

N/A

Report date: 2022/12/07 18:11:14
NME

Base Information

Drug NameFozivudine tidoxil
Drug Alias NameFozivudinum tidoxilum福齐夫定替酯FZT福齐夫定酯Fozivudine +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHeidelberg Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHeidelberg Pharma AG
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A